Effect of <i>VKORC1</i> Haplotypes on Transcriptional Regulation and Warfarin Dose

Abstract

VKORC1 haplotypes can be used to stratify patients into low-, intermediate-, and high-dose warfarin groups and may explain differences in dose requirements among patients of different ancestries. The molecular mechanism of this warfarin dose response appears to be regulated at the transcriptional level.